Screening for Hepatocellular Carcinoma
Author
Source
International Journal of Hepatology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-10-17
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Hepatocellular carcinoma is one of the most serious complications of chronic liver disease and is the third most lethal cancer worldwide.
Symptoms emerge very late in the course of its natural history with an attendant poor outcome.
Screening is of paramount importance in a successful strategy to treat hepatocellular carcinoma.
A successful screening program rests the availability of an at-risk population, reliable diagnostics tests that are able to diagnose a condition at a stage where effective, and relatively simple and acceptable treatments are available.
In hepatocellular carcinoma, all patients with liver cirrhosis or chronic hepatitis B virus infection are at risk.
Six monthly ultrasound and alpha-foetoprotein determination form the backbone of the screening program.
Newer modalities and tests show promise but have not supplanted the standard tests.
American Psychological Association (APA)
Lui, Hock-Foong. 2011. Screening for Hepatocellular Carcinoma. International Journal of Hepatology،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-466053
Modern Language Association (MLA)
Lui, Hock-Foong. Screening for Hepatocellular Carcinoma. International Journal of Hepatology No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-466053
American Medical Association (AMA)
Lui, Hock-Foong. Screening for Hepatocellular Carcinoma. International Journal of Hepatology. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-466053
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-466053